Peripheral T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease.
Sign Up to like & getrecommendations! Published in 2017 at "Cancer treatment reviews"
DOI: 10.1016/j.ctrv.2017.09.002
Abstract: Patients with relapsed or refractory peripheral T-cell lymphoma display a dismal prognosis and their therapy represents an unmet medical need, as the best treatment strategy is yet to be determined. Exciting data on novel targeted… read more here.
Keywords: relapsed refractory; cell lymphomas; lymphomas focusing; focusing novel ... See more keywords